FDA Clears Tool to Aid in Identifying Patients With Low Ejection Fraction

The FDA has cleared the Eko Low Ejection Fraction Tool, an algorithm intended to aid clinicians in identifying LVEF less than or equal to 40%.

Related Keywords

Paul Friedman ,Drug Administration ,Eko Low Ejection Fraction Tool ,Mayo Clinic ,Cardiovascular Medicine ,Early Detection Platform ,